Posts in: investor (2)

100× scale-up of NCT production achieved
press releaseinvestornutraceuticalsmedicine
eXoZymes achieves 100× scale-up of NCT production using exozymes, demonstrating near-perfect feedstock conversionDecember 11, 2025
LA Weekly: The Enzyme Frontier: eXoZymes Unlocks a New Era for Cannabinoid Nutraceuticals and Pharma
investornutraceuticalsmedicinepress clippings
LA Weekly: The Enzyme Frontier - eXoZymes Unlocks a New Era for Cannabinoid Nutraceuticals and PharmaNovember 20, 2025
Slack Capital report
investorpress clippings
Slack Capital report: EXOZ is a once-in-a-lifetime opportunityNovember 19, 2025
'The Upside' interview: Michael Heltzen & Lou Basenese
heltzeninvestornutraceuticalsmedicinepress clippingsvideo
'The Upside' interview: Michael Heltzen & Lou BaseneseNovember 18, 2025
Transcript: EXOZ Q3 2025 update
investor
Transcript: EXOZ Q3 2025 updateNovember 14, 2025
EXOZ 2025 Q3 Update
press releaseinvestor
eXoZymes provides third quarter 2025 update at 5PM EST todayNovember 13, 2025
CSO Tyler Korman - and Chief of Staff, Amy Lunzer
talentpress releaseinvestor
eXoZymes announces cell-free biomanufacturing pioneer, Tyler Korman, as CSO & Amy Lunzer as Chief of StaffNovember 13, 2025
CSO, Tyler Korman
talentinvestorvideo
Co-founder of eXoZymes and cell-free biomanufacturing pioneer, Tyler Korman, speaks to his new role as CSONovember 13, 2025
CEO, Michael Heltzen is interviewed by Jane King
heltzeninvestorpress clippingsvideo
Jane King interviews CEO, Michael Heltzen, in New YorkNovember 12, 2025
2025 Q3 Earnings Call
press releaseinvestor
eXoZymes to host third quarter 2025 update on Thursday November 13, 2025, at 5PM ESTNovember 10, 2025
Previous page
Page 2 of 8
Next page